Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$403K Buy
5,060
+154
+3% +$12.1K 0.01% 508
2019
Q2
$410K Sell
4,906
-88
-2% -$7.01K 0.01% 514
2019
Q1
$395K Sell
4,994
-308
-6% -$22.5K 0.01% 509
2018
Q4
$354K Sell
5,302
-352
-6% -$24.4K 0.01% 486
2018
Q3
$452K Sell
5,654
-308
-5% -$23K 0.01% 485
2018
Q2
$402K Buy
5,962
+1,078
+22% +$78.3K 0.01% 480
2018
Q1
$376K Sell
4,884
-990
-17% -$73.2K 0.01% 481
2017
Q4
$401K Buy
5,874
+748
+15% +$49.7K 0.01% 487
2017
Q3
$321K Sell
5,126
-4,708
-48% -$281K 0.01% 488
2017
Q2
$545K Sell
9,834
-4,290
-30% -$223K 0.02% 374
2017
Q1
$709K Sell
14,124
-4,180
-23% -$204K 0.03% 319
2016
Q4
$906K Buy
+18,304
New +$928K 0.04% 254

Other funds holding XYL

Neuburgh Advisers's XYL Position: Q3 2019 in Review

Neuburgh Advisers increased its Xylem (XYL) stake by 3.1% in Q3 2019, buying an estimated $12.1K and bringing the position to 5,060 shares worth $403K. The position accounts for 0.01% of the portfolio, ranked #508.

Neuburgh Advisers first reported a position in XYL in Q4 2016 and has held it in 12 quarters since. The position peaked at $906K in Q4 2016. 677 funds tracked by Wall St. Rank hold XYL as of Q3 2019.

  • Neuburgh Advisers held 5,060 shares of Xylem worth $403K as of Q3 2019.
  • Neuburgh Advisers bought 154 Xylem shares in Q3 2019, an estimated $12.1K.
  • Xylem made up 0.01% of Neuburgh Advisers's portfolio in Q3 2019, its #508 holding.
  • Neuburgh Advisers first reported a position in Xylem in Q4 2016 and has held it in 12 quarters since.
  • Neuburgh Advisers's Xylem position peaked at $906K in Q4 2016.
  • 677 funds tracked by Wall St. Rank held Xylem as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.